p-Coumaric acid mitigates passive avoidance memory and hippocampal synaptic plasticity impairments in aluminum chloride-induced Alzheimer's disease rat model
[Display omitted] •p-CA alleviated AlCl3-induced passive avoidance memory deficit in rats.•p-CA improved hippocampal synaptic plasticity impairment in AlCl3-exposed rats.•p-CA lowered accumulation of Aβ plaque in the hippocampal neurons of AlCl3-treated rats. The present study was designed to determ...
Gespeichert in:
Veröffentlicht in: | Journal of functional foods 2022-07, Vol.94, p.105117, Article 105117 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•p-CA alleviated AlCl3-induced passive avoidance memory deficit in rats.•p-CA improved hippocampal synaptic plasticity impairment in AlCl3-exposed rats.•p-CA lowered accumulation of Aβ plaque in the hippocampal neurons of AlCl3-treated rats.
The present study was designed to determine the effects of p-coumaric acid (p-CA), a phenolic compound, on passive avoidance memory function and hippocampal long-term potentiation (LTP) in an Alzheimer's disease (AD) rat model induced by aluminum chloride (AlCl3). p-CA (100 mg/kg; P.O.) was administered concomitantly with AlCl3 (100 mg/kg; P.O.) for 42 consecutive days. Results of this study revealed an attenuation of memory capacity, which was accompanied by a reduction in both components of LTP (field excitatory postsynaptic potentials slope and population spike amplitude) and an increase in amyloid-beta (Aβ) plaques production in the AlCl3-exposed rats. Intriguingly, treatment with p-CA improved passive avoidance memory dysfunction, ameliorated hippocampal LTP impairment, and hindered Aβ plaque accumulation in the hippocampal dentate gyrus of AlCl3-treated rats. This data provides evidence that p-CA improves AlCl3-induced passive avoidance memory decline, which may be partly related to amelioration of synaptic dysfunction and suppression of Aβ plaque formation. |
---|---|
ISSN: | 1756-4646 2214-9414 |
DOI: | 10.1016/j.jff.2022.105117 |